White Paper on innovative funding for vaccine development
New vaccines for tuberculosis
On the occasion of the World Vaccine Congress in Lyon, TBVI wrote a White Paper explaning how innovative funding can fuel research and development of new TB vaccines.
TBVI's vice-president Joris Vandeputte is attending the congress to present an innovative funding model that should enable the development of new, more effective vaccines against tuberculosis.
Read the White Paper here.
TBVI
